How much funding has Elektrofi raised?

Elektrofi has raised $152.3M in total funding, most recently a Series C round.

Who are Elektrofi's investors?

Elektrofi's investors include RA Capital Management, Royalty Pharma, SR One, Novo Holdings A/S, TPG Life Sciences Innovation, Marshall Wace.

Where is Elektrofi headquartered?

Elektrofi is headquartered in Boston, Massachusetts, United States.

What industry is Elektrofi in?

Elektrofi operates in Life Sciences, Biotech, Drug Discovery, Healthcare.

How many employees does Elektrofi have?

Elektrofi has 51-200 employees.

Elektrofi

Acquired

Formulating the future of biologics.

Boston, United States · Founded 2016 · $152.3M raised

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: elektrofi.com
Total Funding: $152.3M
Last Round: $112.3M Series COct 2024
Rounds: 2

About

Elektrofi is a biopharmaceutical formulation technology company revolutionizing the delivery of biologic therapies by enabling subcutaneous administration of medicines traditionally given intravenously. Using its proprietary Hypercon microparticle platform, Elektrofi partners with biopharmaceutical companies to develop hyper-concentrated, stable formulations of monoclonal antibodies and therapeutic proteins, giving patients more convenient treatment options.

Summary

Elektrofi is a Life Sciences company based in Boston, United States, founded in 2016. It has raised $152.3M in total across 2 rounds, most recently a $112.3M Series C round in Oct 2024. Investors include RA Capital Management, Royalty Pharma and SR One.

LinkedIn X (Twitter)